0001193125-24-000715.txt : 20240201 0001193125-24-000715.hdr.sgml : 20240201 20240102163158 ACCESSION NUMBER: 0001193125-24-000715 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Theratechnologies Inc. CENTRAL INDEX KEY: 0001512717 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2015 PEEL STREET STREET 2: 5TH FLOOR CITY: MONTREAL STATE: A8 ZIP: H3A 1T8 BUSINESS PHONE: 514-336-7800 MAIL ADDRESS: STREET 1: 2015 PEEL STREET STREET 2: 5TH FLOOR CITY: MONTREAL STATE: A8 ZIP: H3A 1T8 CORRESP 1 filename1.htm CORRESP

Theratechnologies Inc.

2015 Peel Street, Suite 1100

Montréal, Québec H3A 1T8

Canada

January 2, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Daniel Crawford

 

Re:

Theratechnologies Inc.

Registration Statement on Form F-3

Filed on December 21, 2023

File No. 333-276196

Ladies and Gentlemen:

Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Theratechnologies Inc. (the “Registrant”) hereby respectfully requests acceleration of the effective date of the above-referenced Registration Statement on Form F-3, File No. 333-276196 (the “Registration Statement”), so that it may become effective at 4:00pm EST on January 3, 2024 or as soon thereafter as practicable.

Please do not hesitate to contact Martin C. Glass of Jenner & Block LLP at (212) 891-1672 with any questions or comments concerning this letter.

 

Very truly yours,
THERATECHNOLOGIES INC.

/s/ Jocelyn Lafond

Jocelyn Lafond
General Counsel and Corporate Secretary

Cc: Martin C. Glass, Jenner & Block LLP